Article Text

other Versions

PDF
A double-blind, randomised, placebo-controlled trial of oral midazolam plus oral ketamine for sedation of children during laceration repair
  1. Shiri Barkan1,
  2. Rachelle Breitbart1,2,
  3. Galit Brenner-Zada1,
  4. Michal Feldon1,
  5. Amit Assa1,
  6. Michal Toledano3,
  7. Sofia Berkovitch3,
  8. Itai Shavit4,
  9. Eran Kozer1,2
  1. 1Pediatric Emergency Unit, Assaf Harofeh Medical Center, Zerifin, Israel
  2. 2Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
  3. 3Department of Pharmacy, Assaf Harofeh Medical Center, Zerifin, Israel
  4. 4Department of Pediatric Emergency, Rambam Health Care Campus, Haifa, Israel
  1. Correspondence to Dr Shiri Barkan, Pediatric Emergency Unit, Assaf Harofeh Medical Center, Zerifin 70300, Israel; shiriraash{at}gmail.com

Abstract

Objectives To compare the efficacy of oral midazolam alone with a combination of oral midazolam and ketamine in children requiring laceration repair.

Design A randomised, double-blind, placebo-controlled study.

Setting Paediatric emergency department.

Participants Children 1–10 years of age with lacerations requiring sedation.

Interventions Using a computer-generated sequence, children were randomly assigned in blocks of four to one of two groups: oral midazolam (0.5 mg/kg) plus oral placebo and oral midazolam (0.5 mg/kg) plus oral ketamine (5 mg/kg). The allocation sequence was kept by the pharmacy staff, and the investigators were blinded to randomisation until statistical analysis of the study was completed.

Main outcome measures Visual Analogue Scale (VAS) assessment by a parent and Sedation Score assessment by an investigator.

Results 60 children were recruited; 29 were assigned for treatment with midazolam and 31 for the combination of midazolam and ketamine. There were no differences in basic demographics and wound characteristics between the groups. VAS assessment by a parent was 4.5±3.3 mm in the midazolam+ketamine group versus 4.4±2.7 mm in the midazolam alone group (mean difference 0.1, CI −1.9 to 1.71). Sedation Score during procedure was lower in the midazolam+ketamine group (mean difference 1.14, 95% CI 0.67 to 1.6). Intravenous sedation was required in two (6%) of the children in the midazolam+ketamine group, and in eight (27%) in the midazolam alone group. p=0.039. No clinically significant adverse effects were documented in either group.

Conclusions No difference was found in pain assessment during local anaesthetic injection between the group treated with midazolam and ketamine, and the group treated with midazolam alone. The combination of oral midazolam and ketamine led to deeper sedation than midazolam alone, with less children requiring intravenous sedation.

Clinical trial registration The trial was registered in www.clinicaltrials.gov as NCT01470157.

  • analgesia/pain control
  • paediatrics, paediatric injury
  • paediatric emergency med
  • paediatric injury
  • paediatrics, paediatric emergency medicine

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.